GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » PharmaCorp Rx Inc (TSXV:PCRX) » Definitions » FCF Margin %

PharmaCorp Rx (TSXV:PCRX) FCF Margin % : -58.24% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is PharmaCorp Rx FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PharmaCorp Rx's Free Cash Flow for the three months ended in Sep. 2024 was C$-0.64 Mil. PharmaCorp Rx's Revenue for the three months ended in Sep. 2024 was C$1.10 Mil. Therefore, PharmaCorp Rx's FCF Margin % for the quarter that ended in Sep. 2024 was -58.24%.

As of today, PharmaCorp Rx's current FCF Yield % is -2.13%.

The historical rank and industry rank for PharmaCorp Rx's FCF Margin % or its related term are showing as below:

TSXV:PCRX' s FCF Margin % Range Over the Past 10 Years
Min: -91.68   Med: 0   Max: 0
Current: -91.68


TSXV:PCRX's FCF Margin % is ranked worse than
78.18% of 110 companies
in the Diversified Financial Services industry
Industry Median: -0.935 vs TSXV:PCRX: -91.68


PharmaCorp Rx FCF Margin % Historical Data

The historical data trend for PharmaCorp Rx's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCorp Rx FCF Margin % Chart

PharmaCorp Rx Annual Data
Trend Dec21 Dec22 Dec23
FCF Margin %
- - -

PharmaCorp Rx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -53.95 -58.24

Competitive Comparison of PharmaCorp Rx's FCF Margin %

For the Shell Companies subindustry, PharmaCorp Rx's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaCorp Rx's FCF Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, PharmaCorp Rx's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PharmaCorp Rx's FCF Margin % falls into.


;
;

PharmaCorp Rx FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PharmaCorp Rx's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-0.519/0
= %

PharmaCorp Rx's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-0.643/1.104
=-58.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaCorp Rx FCF Margin % Related Terms

Thank you for viewing the detailed overview of PharmaCorp Rx's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaCorp Rx Business Description

Traded in Other Exchanges
N/A
Address
303 Wellman Lane, Suite 203, Saskatoon, SK, CAN, S7T 0J1
Website
PharmaCorp Rx Inc foremerly Proton Capital Corp is a Capital Pool Company. The principal business of the company is to identify and evaluate assets or businesses with a view to potentially acquiring them or interest therein by completing a purchase transaction, by exercising an option, or by any concomitant transaction.

PharmaCorp Rx Headlines